Inventors
Douglas S Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee
Publication date
2017/5/2
Patent office
US
Patent number
9637554
Application number
14817754
Description
Related US Application Data Primary Examiner—Brian Whiteman (60) Division of application No. 13/971,662, filed on Aug.(74) Attorney, Agent, or Firm—Medlen & Carroll, LLP
20, 2013, now Pat. No. 9,095,592, which is a (57) ABSTRACT continuation-in-part of application No. 13/330,062,-0 filed on Dec. 19, 2011, now Pat. No. 8,513,212, which Receptor protein kinases (RPTKs) transmit extracellular is a continuation of application No. 12/613,937, filed signals across the plasma membrane to cytosolic proteins, on Nov. 6, 2009, now abandoned. stimulating formation of complexes that regulate key cellu lar functions. Over half of the known tyrosine kinases are (60) Provisional application No. 61/112,406, filed on Nov. implicated in human cancers and are therefore highly prom 7, 2008. ising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically (51) Int. Cl …
Total citations
Scholar articles
DS Conklin, C Eifert, A Kourtidis, X Wang, L Kokabee - US Patent 9,637,554, 2017